Former U.S. Food and Drug Administration (FDA) commissioner David Kessler drew attention last week when he said he thought Juul and other popular vaping manufacturers would be forced to leave the market under proposed FDA rules.
As FDA deadlines approach for regulations on electronic tobacco products, observers say the industry is in for a period of change and consolidation.
As more people become ill from using vaping products, government authorities are beginning to take a hard look at e-cigarettes.
The Prescription Drug Pricing Reduction Act (PDPRA) is expected to work its way through Congress this fall.
The Trump administration’s move to ban certain flavors of e-cigarettes and vaping devices either goes too far or doesn’t go far enough, according to those on opposite sides of the debate.
ResearchAndMarkets.com held a seminar in San Diego on Sept. 12 and 13 entitled, "Managing Your Complaints and Obstacles in Post-Market Requirements – Results from Top Medical Device Observations During an Inspection.”
The FDA has issued new draft guidance for labeling of prescription medications that could be abused, with the goal of making the risks of dependence clearer for health care providers and for patients.